RELAPSING MULTIPLE SCLEROSIS (RMS)

Clinical trials for RELAPSING MULTIPLE SCLEROSIS (RMS) explained in plain language.

Never miss a new study

Get alerted when new RELAPSING MULTIPLE SCLEROSIS (RMS) trials appear

Sign up with your email to follow new studies for RELAPSING MULTIPLE SCLEROSIS (RMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

MS drug tested in chinese patients shows promise

Disease control Completed

This study tested the safety and effectiveness of the drug fingolimod (Gilenya) in Chinese adults and teens with relapsing multiple sclerosis (RMS). About 100 participants took the daily pill for two years while doctors tracked their relapses and side effects. The goal was to see…

Matched conditions: RELAPSING MULTIPLE SCLEROSIS (RMS)

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

RELAPSING MULTIPLE SCLEROSIS (RMS)

Get alerted when new RELAPSING MULTIPLE SCLEROSIS (RMS) trials appear

MS drug tested in chinese patients shows promise